Zejula & White blood cell count decreased

7.9%

of users reported White blood cell count decreased

77.1%

also reported Severe reaction

99.8%

are women

Severe reaction

77.1%

Hospitalization

15.1%

Life-threatening condition

5.8%

Death

1.2%

Disability

0.8%

Zejula: general information

30 - 39 years

0.5%

40 - 49 years

6.1%

50 - 59 years

20.9%

60 - 69 years

35.8%

70 - 79 years

29.1%

80 - 89 years

7.4%

90 - 99 years

0.3%